Connecticut Children's Medical Center — Hartford, Connecticut

Public research footprint of Connecticut Children's Medical Center, compiled from the ClinicalTrials.gov public registry.

340

Registered studies

119

Active

Recruiting now

205

Completed

Stopped or withdrawn

Most-studied conditions

B Acute Lymphoblastic Leukemia · Botryoid-Type Embryonal Rhabdomyosarcoma · Classic Hodgkin Lymphoma · Recurrent Langerhans Cell Histiocytosis

Recently updated registry entries

NCT04320888 — Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic… (Active Not Recruiting)
NCT03907488 — Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in… (Active Not Recruiting)
NCT04166409 — A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Connecticut Children's Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.